Abstract
It is known that umbilical cord blood (UCB) is a rich source of stem cells with practical and ethical advantages. Three important types of stem cells which can be harvested from umbilical cord blood and used in disease treatment are hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs). Since these stem cells have shown enormous potential in regenerative medicine, numerous umbilical cord blood banks have been established. In this study, we examined the ability of banked UCB collected to produce three types of stem cells from the same samples with characteristics of HSCs, MSCs and EPCs. We were able to obtain homogeneous plastic rapidly-adherent cells (with characteristics of MSCs), slowly-adherent (with characteristics of EPCs) and non-adherent cells (with characteristics of HSCs) from the mononuclear cell fractions of cryopreserved UCB. Using a protocol of 48 h supernatant transferring, we successfully isolated MSCs which expressed CD13, CD44 and CD90 while CD34, CD45 and CD133 negative, had typical fibroblast-like shape, and was able to differentiate into adipocytes; EPCs which were CD34, and CD90 positive, CD13, CD44, CD45 and CD133 negative, adherent with cobble-like shape; HSCs which formed colonies when cultured in MethoCult medium.
Similar content being viewed by others
References
Aoki M, Yasutake M, Murohara T (2004) Derivation of functional endothelial progenitor cells from human umbilical card blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 22:994–1002
Barachini S, Trombi L, Danti S et al (2009) Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine. Stem Cells Dev 18(2):293–305
Bompais H, Chagraoui J, Canron X et al (2004) Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells. Blood 103:2577–2584
Bradley MB, Cairo MS (2005) Cord blood immunology and stem cell transplantation. Hum Immunol 66:431–446
Broxmeyer HE, Douglas GW, Hangoc G et al (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 86:3828–3832
Broxmeyer HE, Hangoc G, Cooper S et al (1992) Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation of adults. Proc Natl Acad Sci USA 89:4109–4113
Cardoso AA, Li ML, Batard P et al (1993) Release from quiescence of CD34+CD38–human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 90:8707–8711
Carow C, Hangoc G, Cooper S et al (1991) Mast cell growth factor (c-kit ligand) supports the growth of human multipotential (CFU-GEMM) progenitor cells with a high replating potential. Blood 78:2216–2221
Carow CE, Hangoc G, Broxmeyer HE (1993) Human multipotential progenitor cells (CFU‐GEMM) have extensive replating capacity for secondary CFU-GEMM: an effect enhanced by cord blood plasma. Blood 81:942–949
Crisa L, Cirulli V, Smith KA et al (1990) Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94:3928–3940
Delalat B, Pourfathollah AA, Soleimani M, Mozdarani H, Ghaemi SR, Movassaghpour AA, Kaviani S (2009) Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells. Hematology 14(3):125–132
Eggermann J, Kliche S, Jarmy G et al (2003) Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58:478–486
Fan CL, Li Y, Gao PJ, Liu JJ et al (2003) Differentiation of endothelial progenitor cells from human umbilical cord blood CD 34+ cells in vitro. Acta Pharmacol Sin 24:212–218
Gluckman E, Broxmeyer HA, Auerbach AD et al (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174–1178
Gluckman E, Koegler G, Rocha V (2005) Human leukocyte antigen matching in cord blood transplantation. Semin Hematol 42:85–89
Hildbrand P, Cirulli V, Prinsen RC et al (2004) The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 104:2010–2019
Ingram D, Mead L, Tanaka H et al (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752–2760
Kang HJ, Kim SC, Kim YJ et al (2001) Short-term phytohaemagglutinin-activated mononuclear cells induce endothelial progenitor cells from cord blood CD34+ cells. Br J Haematol 113:962–969
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24(5):1294–1301
Koponen JK, Kekarainen T, Heinonen SE et al (2007) Umbilical cord blood–derived progenitor cells enhance muscle regeneration in mouse hindlimb ischemia model. Mol Ther 15(12):2172–2177
Lansdorp PM, Dragowska W, Mayani H (1993) Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787–791
Lee MW, Choi J, Yang MS et al (2004a) Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun 320(1):273–278
Lee OK, Kuo TK, Chen WM et al (2004b) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103(5):1669–1675
Lee MW, Yang MS, Park JS, Kim HC, Kim YJ, Choi J (2005) Isolation of mesenchymal stem cells from cryopreserved human umbilical cord blood. Int J Hematol 81(2):126–130
Lin RZ, Dreyzin A, Aamodt K, Dudley AC, Melero-Martin JM (2010) Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant. [Epub ahead of print]
Majeti R, Park CY, Weissman IL (2007) Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1(6):635–645
Manca MF, Zwart I, Beo J et al (2008) Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood. Cytotherapy 10(1):54–68
McNiece I, Kubegov D, Kerzic P et al (2000) Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 28:1181–1186
Murga M, Yao L, Tosato G (2004a) Derivation of endothelial cells from CD34- umbilical cord blood. Stem Cells 22(3):385–395
Murga M, Yao L, Tosato G (2004b) Derivation of endothelial cells from CD34–umbilical cord blood. Stem Cells 22:385–395
Peichev M, Naiyer A, Pereira D et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95:952–958
Pesce M, Orlandi A, Iachininoto MG (2003) Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ Res 93:e51–e62
Peters R, Wolf MJ, van den Broek M, Nuvolone M, Dannenmann S, Stieger B, Rapold R, Konrad D, Rubin A, Bertino JR, Aguzzi A, Heikenwalder M, Knuth AK (2010) Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture. PLoS One 5(12):e15689
Phuc PV, Nhung TH, Loan DT, Chung DC, Ngoc PK (2011) Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells. In Vitro Cell Dev Biol Anim 47(1):54–63
Schmidt D, Breymann C, Weber A et al (2004) Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg 78:2094–2098
Shin JW, Lee DW, Kim MJ, Song KS, Kim HS, Kim HO (2005) Isolation of endothelial progenitor cells from cord blood and induction of differentiation by ex vivo expansion. Yonsei Med J 46(2):260–267
Simons M (2005) Angiogenesis: where do we stand now? Circulation 111:1556–1566
Spring FA, Dalchau R, Daniels GL et al (1988) The Ina and Inb blood group antigens are located on a glycoprotein of 80, 000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene. Immunology 64(1):37–43
Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y, Takahashi K, Homma K, Oyamada N, Inuzuka M, Sonoyama T, Ebihara K, Tamura N, Itoh H, Suemori H, Nakatsuji N, Okano H, Yamanaka S, Nakao K (2009) Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS lett 583:1029
Vanneaux V, El-Ayoubi F, Delmau C, Driancourt C, Lecourt S, Grelier A, Cras A, Cuccuini W, Soulier J, Lataillade JJ, Lebousse-Kerdiles MC, Oury JF, Sibony O, Marolleau JP, Benbunan M, Uzan G, Larghero J (2010) In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: are we ready for clinical application? Cell Transplant 19(9):1143–1155
Zhu S, Malhotra A, Zhang L, Deng S, Zhang T, Freedman NJ, Storms R, Peppel K, Goldschmidt-Clermont PJ, Dong C (2010) Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice. Atherosclerosis 212:63
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Phuc, P.V., Ngoc, V.B., Lam, D.H. et al. Isolation of three important types of stem cells from the same samples of banked umbilical cord blood. Cell Tissue Bank 13, 341–351 (2012). https://doi.org/10.1007/s10561-011-9262-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10561-011-9262-4